Kronox Lab Sciences Limited

KRONOX Lab Sciences Limited will hold a board meeting on November 5, 2026, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2026, and the trading window for directors, officers, and designated employees is closed from October 1, 2026, until 48 hours after the results are declared.

KRONOX LAB SCIENCES LIMITED announced that its board approved the acquisition of a plant measuring approximately 5000 square meters from Axiom Chemicals Private Limited, located in the Dahej Special Economic Zone, for a cash consideration to be funded through internal accruals. The acquisition, expected to be completed within one month subject to approvals, will expand manufacturing capacity for business growth, and does not involve the acquisition of Axiom Chemicals Private Limited itself, which is engaged in the business of chemicals.

KRONOX LAB SCIENCES LIMITED submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, received from K?n Technologies Limited, its Registrar and Share Transfer Agent, and furnished to the National Stock Exchange of India Limited and BSE Limited.

Kronox Lab Sciences Limited will close its trading window for designated persons from Thursday, October 1, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and will reopen 48 hours after the announcement of the unaudited financial results for the quarter and half year ending September 30, 2026, by the company's board of directors.

KRONOX Lab Sciences Limited informed the National Stock Exchange of India Limited and BSE Limited that Wednesday, September 09, 2026, has been set as the record date for determining shareholders eligible to receive a final dividend of Rs 0.50 per equity share of Rs 10 each for the financial year ended March 31, 2026, following a board recommendation in May 2026.

Indo Borax and Chemicals Limited has initiated a public offer, or Open Offer, to acquire shares of Kronox Lab Sciences Limited following the Acquirer's acquisition of a substantial stake, triggering requirements under Indian takeover regulations. The announcement was made on August 20, 2026, with Zenrock Chemicals Private Limited acting as the Promoter Authorised Representative for Indo Borax. Key details of the offer, including the price and tendering period, will be disclosed in a Detailed Public Statement expected to be published within five working days, by August 28, 2026. Kronox Lab Sciences Limited is obligated to maintain normal business operations and adhere to specific restrictions outlined by SEBI, including limitations on asset sales, borrowing, and share issuances, while also facilitating the Open Offer process with the assistance of IIFL Capital Services Limited.

Indo Borax and Chemicals Limited, alongside Promoter Actioning Company Zenrock Chemicals Private Limited, has launched an Open Offer to acquire shares from public shareholders of Kronox Lab Sciences Limited, a company listed on the BSE and NSE. This action follows a Share Purchase Agreement where Indo Borax will acquire a 74.21% stake from existing shareholders, triggering the Open Offer as a regulatory requirement. The Open Offer seeks to acquire 95,70,000 shares, representing 25.79% of the Voting Share Capital, and is not subject to a minimum acceptance level. A Detailed Public Statement, including the offer price, will be released within five working days, by August 28, 2026. IIFL Capital Services Limited is managing the Open Offer, which is compliant with SEBI (SAST) Regulations, and the Acquirer will ensure Kronox maintains the required minimum public shareholding.

KRONOX Lab Sciences Limited informed the National Stock Exchange of India Limited and BSE Limited that its register of members and share transfer books will be closed from September 10, 2026, to September 16, 2026, for the purpose of paying a final dividend for the financial year 2025-26, contingent upon approval at the company’s 17th Annual General Meeting scheduled for September 16, 2026.

KRONOX Lab Sciences Limited informed the National Stock Exchange of India Limited and BSE Limited that its register of members and share transfer books will be closed from September 10, 2026, to September 16, 2026, for the purpose of paying a final dividend for the financial year 2025-26, contingent upon approval at the company’s 17th Annual General Meeting scheduled for September 16, 2026.

KRONOX Lab Sciences Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, the company said in a filing. The trading window for the company's securities will be closed for directors, officers, and designated employees from July 1, 2026, and will remain closed until 48 hours after the financial results are declared.